Commentary: The jury is out-expanding eligibility for lung transplantation after hematopoietic stem cell transplantation

J Thorac Cardiovasc Surg. 2022 Apr;163(4):1561-1562. doi: 10.1016/j.jtcvs.2020.11.103. Epub 2020 Nov 30.

Authors

Samantha E Halpern¹, Samuel J Kesseli², Matthew G Hartwig³

Affiliations

¹ School of Medicine, Duke University, Durham, NC.
² Department of Surgery, Duke University Medical Center, Durham, NC.
³ Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC. Electronic address: matthew.hartwig@duke.edu.

PMID: 33419550
DOI: 10.1016/j.jtcvs.2020.11.103

No abstract available

Publication types

Editorial
Comment

MeSH terms

Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Lung Transplantation* / adverse effects